• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Lucy Scientific Discovery (NASDAQ: LSDI) Acquisitions Create 'Golden Opportunity' for Growth, Success

    9/26/23 8:30:00 AM ET
    $LSDI
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $LSDI alert in real time by email

    NEW YORK, Sept. 26, 2023 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lucy Scientific Discovery (NASDAQ:LSDI) announces the availability of a broadcast titled, "From Instagram to High Times: Unpacking the Power of Vast User Networks."

    To hear the AudioPressRelease, please visit: The NetworkNewsAudio News Podcast

    To view the full editorial, please visit: https://nnw.fm/aK4Qa

    Enter Lucy Scientific Discovery (NASDAQ:LSDI), a company that has recognized the value in this counterintuitive approach. Lucy's recent share purchase agreement to acquire the total intellectual property (IP) of High Times shows that the company truly understands the immense value of a large, loyal audience. In an all-stock transaction, the acquisition provides a stream of high-margin licensing and royalty income from the well-regarded High Times. More importantly, with its massive following, the High Times acquisition offers a golden opportunity for Lucy Scientific Discovery to introduce and distribute its products to a captive, engaged audience, while benefitting from significant early-stage revenue.

    On closing, Lucy will acquire all the brand rights and fully intends to monetize the broad-based IP through both current and future royalty agreements. Lucy also plans to extend and enhance the existing domestic and international licensing arrangements currently held by High Times, including consumer products and merchandise. The company expects to preserve the core essence of the High Times brands and its followers while simultaneously expanding the follower base and pursuing new avenues of growth and development.

    About Lucy Scientific Discovery Inc.

    Lucy Scientific Discovery is a NASDAQ-listed company with holdings and operations in a variety of psychotropic businesses. The company holds a Controlled Drugs and Substances Dealer's License granted by Health Canada's Office of Controlled Substances. Lucy Scientific Discovery and its wholly owned subsidiary, LSDI Manufacturing Inc., operate under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada). This specialized license authorizes LSDI to develop, sell, deliver and manufacture pharmaceutical-grade active pharmaceutical ingredients ("APIs") used in controlled substances and their raw material precursors. With a focus on pioneering innovative therapies for patients in need, Lucy Scientific Discovery is dedicated to advancing the understanding and applications of psychotropic medicines, improving mental-health outcomes and enhancing well-being for individuals worldwide.

    For more information about the company, visit www.LucyScientific.com.

    NOTE TO INVESTORS: The latest news and updates relating to LSDI are available in the company's newsroom at https://ibn.fm/LSDI

    About NetworkNewsWire

    NetworkNewsWire ("NNW") is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, NNW brings its clients unparalleled recognition and brand awareness. NNW is where breaking news, insightful content and actionable information converge.

    To receive SMS text alerts from NetworkNewsWire, text "STOCKS" to 77948 (U.S. Mobile Phones Only)

    For more information, please visit https://www.NetworkNewsWire.com

    Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: https://www.NetworkNewsWire.com/Disclaimer

    NetworkNewsWire

    New York, NY

    www.NetworkNewsWire.com

    212.418.1217 Office

    [email protected]

    NetworkNewsWire is powered by IBN



    Primary Logo

    Get the next $LSDI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LSDI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LSDI
    Leadership Updates

    Live Leadership Updates

    See more
    • Lucy Scientific Discovery Inc. Taps Fortune 500 Veteran and Current Executive Chairman Richard Nanula as New CEO

      VANCOUVER, British Columbia, July 13, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a leader and innovator in the psychotropic industry, announced the appointment of current Executive Chairman Richard Nanula as the new Chief Executive Officer, effective immediately. Nanula will retain his Chairman role while succeeding Chris McElvany as Chief Executive Officer, who will transition into a consulting role with the Company. Nanula brings to Lucy decades of senior leadership experience from several of the largest companies in the world having been a Senior Executive at The Walt Disney Company, Amgen, Colony Capital and Starwood Hotels and Resorts. Over the course of h

      7/13/23 9:00:00 AM ET
      $LSDI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lucy Scientific Discovery Appoints Former B.C. Solicitor General Kash Heed as a Special Advisor

      VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. ("Lucy" or "The Company") (NASDAQ:LSDI), an early-stage psychedelics manufacturing company, announced today that former British Columbia Solicitor General Kash Heed has joined the company as a Special Advisor. Among other important contributions, Mr. Heed will apply his knowledge from decades of public service to help the company successfully navigate Canada's rapidly evolving drug policy landscape and growing budget focused on mental health and safe-supply programs. Mr. Heed started his public service 44 years ago with the Vancouver Police Department (VPD). With the VPD, he pioneered initia

      3/29/23 9:00:00 AM ET
      $LSDI
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $LSDI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Mcelvany Christopher acquired $284,167 worth of shares (118,403 units at $2.40) and converted options into 366,187 shares

      4 - Lucy Scientific Discovery, Inc. (0001865127) (Issuer)

      2/15/23 9:28:18 PM ET
      $LSDI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4: Kazeminy Assad J acquired $204,000 worth of shares (85,000 units at $2.40)

      4 - Lucy Scientific Discovery, Inc. (0001865127) (Issuer)

      2/15/23 8:56:34 PM ET
      $LSDI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4: Susin Livio acquired $22,342 worth of shares (9,309 units at $2.40), increasing direct ownership by 7% to 134,809 units

      4 - Lucy Scientific Discovery, Inc. (0001865127) (Issuer)

      2/15/23 8:55:48 PM ET
      $LSDI
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $LSDI
    Financials

    Live finance-specific insights

    See more
    • Lucy Scientific Discovery Expands its Reach in the Global Wellness Market with BlueSky Wellness Acquisition

      VANCOUVER, BC / ACCESSWIRE / September 12, 2023 / Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a publicly traded company focused on the development, sale, delivery, and manufacturing of psychotropic products, recently announced its acquisition of all High Times IP and brand assets - has just announced the acquisition of BlueSky Wellness Inc., along with the full BlueSky portfolio of brands adding psychotropic products to its catalog, expanding its footprint into the global wellness market. The BlueSky Wellness family of wellness focused ecommerce brands includes Keoni, Keoni Sport, Blush Wellness and AMMA Healing, which have generated over $20 million in revenue in each of the last two y

      9/12/23 11:20:00 PM ET
      $LSDI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lucy Scientific Acquires High Times Intellectual Property, Including Existing Licensing Agreements in All-Stock Transaction

      VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. ("Lucy" or "the Company") (NASDAQ:LSDI), a leading psychotropic innovator announces the acquisition of the intellectual property (IP) of High Times, the most recognizable and iconic brand in the cannabis industry. This acquisition provides a stream of high-margin licensing and royalty income from the well-regarded High Times, Cannabis Cup, and 420.com brands, including their respective domain names.  Lucy will issue 19.9% of its outstanding stock to High Times and make payments semi-annually for the next 5 years based on EBITDA generated from the acquired IP, which can be settled with either s

      9/7/23 8:00:36 AM ET
      $LSDI
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $LSDI
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

      Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide, announces that it has a hearing scheduled for June 25, 2024 before a Nasdaq Hearings Panel (the "Panel") regarding its plan to regain compliance with Nasdaq Listing Rule 5550(b) (the "Stockholders' Equity Rule"). On May 21, 2024, the Company received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") that, per Nasdaq Listing Rule 5250(c)(1) (the "Filings Rule"), the Company is delinquent in filing its Quarterly Report on Form 1

      5/28/24 4:05:00 PM ET
      $LSDI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lucy Scientific Discovery Inc. Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement

      Lucy Scientific Discovery Inc. (NASDAQ:LSDI), a Company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide announces that the Company will effect a one-for-ten (1-10) reverse split of its common shares. The Company is effecting the reverse split in an effort to regain compliance with the $1.00 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). The reverse share split will become effective on Monday, February 26, 2024 (the "Effective Date"), and the shares are expected to begin trading on the split-adjusted b

      2/16/24 4:05:00 PM ET
      $LSDI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lucy Scientific Discovery's Alternative Mental Health Treatments to Provide Opportunity to Improve Mental Health

      DENVER, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (NASDAQ:LSDI) is a pioneer in alternative mental health treatments and looking to grab its share of the leadership mantle, as it uncovers alternative mental health treatments. From herbal remedies to psychedelics, like psilocybin and MDMA, Lucy Scientific is working to provide the ingredients for groundbreaking mental health therapies and are well positioned to support this space as it continues to grow. Mental Health Refocus Mental health issues and treatments are nearly as old as mankind, but, as mental health disorders reach epidemic proportions, affecting millions of Americans every year, it seems that the tre

      10/18/23 7:00:00 AM ET
      $LSDI
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $LSDI
    SEC Filings

    See more
    • Lucy Scientific Discovery Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Lucy Scientific Discovery, Inc. (0001865127) (Filer)

      7/1/24 8:30:14 AM ET
      $LSDI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Lucy Scientific Discovery Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - Lucy Scientific Discovery, Inc. (0001865127) (Filer)

      5/28/24 5:19:04 PM ET
      $LSDI
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form NT 10-Q filed by Lucy Scientific Discovery Inc.

      NT 10-Q - Lucy Scientific Discovery, Inc. (0001865127) (Filer)

      5/15/24 5:24:31 PM ET
      $LSDI
      Biotechnology: Pharmaceutical Preparations
      Health Care